Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FinnBladder 9: Fluorescence Cystoscopy and Mitomycin-C in Bladder Cancer
NCT01675219Phase 3Unknown
- Sponsor
- Turku University Hospital
- Start
- Dec 2012
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hexaminolevulinate, mitomycin c in bladder cancer, sponsored by Turku University Hospital. Status: unknown.
02
Drugs
hexaminolevulinatemitomycin c
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT01675219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01675219.